[{"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "65629", "recalling_firm": "Max Huber Research Labs, Inc.", "address_1": "767 Fifth Avenue", "address_2": "N/A", "postal_code": "10153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-814-2013", "product_description": "LA MER the spf 18 fluid tint , broad spectrum spf 18, 1.7 fl.oz. liq./50 ml, Shade LIGHT 02, UPC 7 47930 00481 3,  MAX HUBER RESEARCH LABS INC., DIST. NEW YORK, N.Y. 10022 -- MADE IN BELGIUM", "product_quantity": "49,845 tubes (total for all products)", "reason_for_recall": "Subpotent Drug: Avobenzone 3%, one of the active sunscreen ingredients may be subpotent and sunscreen effectiveness may be less than labeled", "recall_initiation_date": "20130627", "center_classification_date": "20130722", "termination_date": "20180518", "report_date": "20130731", "code_info": "all lots currently in the market shipped before June 2013", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA075682"], "brand_name": ["IBU"], "generic_name": ["IBUPROFEN"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-682", "55111-683", "55111-684"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IBUPROFEN"], "rxcui": ["197805", "197806", "197807", "206905", "206913", "206917"], "spl_id": ["a7977972-4353-9ca0-d419-e37039010e7d"], "spl_set_id": ["24731405-219c-79b4-ecf0-7d5fbfda94ba"], "package_ndc": ["55111-682-09", "55111-682-01", "55111-682-05", "55111-683-30", "55111-683-50", "55111-683-09", "55111-683-01", "55111-683-05", "55111-684-30", "55111-684-50", "55111-684-60", "55111-684-09", "55111-684-01", "55111-684-05"], "is_original_packager": [true], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "95620", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "USA Nationwide", "recall_number": "D-0047-2025", "product_description": "IBU (ibuprofen) 600 mg tablets, 500-count bottle, Rx Only,  Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 55111-683-05", "product_quantity": "3416 botttles", "reason_for_recall": "Failed Tablet/Capsule Specifications", "recall_initiation_date": "20241029", "center_classification_date": "20241115", "report_date": "20241127", "code_info": "Lot #: C5406201, Exp 03/31/2028"}, {"status": "Ongoing", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81646", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide including Puerto Rico.", "recall_number": "D-0303-2019", "product_description": "Amlodipine and Valsartan Tablets 5 mg/160 mg, (a) 30-count bottles (NDC 0093-7690-56) & 90-count bottles (NDC 0093-7690-98), RX Only, Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 9777402, Israel, Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454.", "product_quantity": "120,394 bottles", "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.", "recall_initiation_date": "20181127", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "NDC 0093-7690-56 & NDC 0093-7690-98  Lot # 23X017, 23X018, 23X019, 23X020, 23X022, 23X023, 23X024"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "17 units", "code_info": "Rx #'s:C0397709  C0403979  C0387544  C0387581  C0387806  C0388157  C0395001  C0397028  C0397915  C0400555  C0400709  C0404008  C0405234  C0390252  C0391731  C0393592  C0406126", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "TESTOSTERONE CYP/ESTRADIOL CYP 50MG/2MG/ML INJECTABLE\t5 ML;  TESTOSTERONE CYPIONATE 50MG/ML INJECTABLE\t12 ML  \t2.5 ML  (4 DIFFERENT PRODUCTS)\t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t5 ML;  \t  \t  TESTOSTERONE PROPIONATE 200MG/ML INJECTABLE\t10 ML", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1621-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Melrose Park", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078052"], "brand_name": ["FOSPHENYTOIN"], "generic_name": ["FOSPHENYTOIN SODIUM"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-403"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["FOSPHENYTOIN SODIUM"], "rxcui": ["1670195", "1670200"], "spl_id": ["84385df0-4793-47d2-8e49-5c84668a0ba3"], "spl_set_id": ["b60c9c82-e5c7-4e05-98c7-5bbba4af04b2"], "package_ndc": ["63323-403-01", "63323-403-02", "63323-403-04", "63323-403-10"], "is_original_packager": [true], "upc": ["0363323403010", "0363323403041"], "unii": ["7VLR55452Z"]}, "product_type": "Drugs", "event_id": "68152", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "2045 Cornell Ave", "address_2": "", "postal_code": "60160-1002", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1428-2014", "product_description": "Fosphenytoin Sodium Injection, USP, 100 mg PE/2 mL (50 mg PE/mL) (PE= phenytoin sodium equivalents)  2 mL Single Use Vial, Rx only, Manufactured for APP Fresenius Kabi USA, LLC Lake Zurich, IL 60047, NDC 63323-403-02", "product_quantity": "2,070,500 vials", "reason_for_recall": "Presence of Particular Matter: Potential glass delamination and consistent with glass particulates observed in sample vials.", "recall_initiation_date": "20140502", "center_classification_date": "20140709", "termination_date": "20160524", "report_date": "20140716", "code_info": "Lot #  6003850; 04/14  6003926; 05/14  6004052; 05/14  6004053; 05/14  6004093; 06/14  6004094; 06/14  6004199; 07/14  6004200; 07/14  6004509; 08/14  6004510; 08/14  6004661; 09/14  6005157; 11/14  6005158; 11/14  6005197; 11/14  6005198; 11/14  6005446; 01/15  6005447; 01/15  6005702; 03/15  6005703; 03/15  6005790; 03/15  6005791; 03/15  6006005; 05/15  6006006; 05/15  6006091; 05/15  6006211; 06/15  6006212; 06/15  6006396; 07/15  6006397; 07/15", "more_code_info": ""}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "", "code_info": "Lot#: 20171201@84, BUD: 05/30/2018; 20180125@31, BUD 07/24/2018; 20180209@106, BUD 08/08/2018; 20171011@69, BUD 04/09/2018; 20171019@10, BUD 04/17/2018; 20171106@103, BUD 05/05/2018.", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "Estradiol 10 mg  (SD) pellets in amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800.", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0673-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "90239", "recalling_firm": "Teva Pharmaceuticals USA Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the US Market", "recall_number": "D-0988-2022", "product_description": "Alprostadil Injection USP 500 mcg/mL, 1 mL Single Dose Vial, 5 vials per Carton, Rx Only, Carton NDC 0703-1501-02, Distributed by: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054,  Vial NDC 0703-1501-01", "product_quantity": "3109 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing", "recall_initiation_date": "20220518", "center_classification_date": "20220607", "termination_date": "20231208", "report_date": "20220615", "code_info": "Lot #:100022404, Exp Date 10/2022; Lot #:100023333, Exp Dat 12/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86066", "recalling_firm": "Ferring Pharmaceuticals Inc", "address_1": "100 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States.", "recall_number": "D-1506-2020", "product_description": "STIMATE (desmopressin acetate) Nasal Spray1.5 mg/mL, 2.5 mL glass vial with spray cap, Rx only, Manufactured for: CSL Behring LLC, King of Prussia, PA 19406-0901; By: Ferring GmbH, Kiel, Germany, NDC 0053-6871-00", "product_quantity": "29,371 nasal sprays", "reason_for_recall": "Superpotent Drug", "recall_initiation_date": "20200721", "center_classification_date": "20200817", "termination_date": "20231013", "report_date": "20200826", "code_info": "Lot #    N14134C, exp. date 07 2020  N15378G, exp. date  09 2020  N17445N, exp. date 02 2020  P11326AA, exp. date 02 2021  P11326C, exp. date 02 2021  P13209L, exp. date 04 2021  P13212H, exp. date 06 2021  P13755A, exp. date 06 2021  P13756P, exp. date 08 2021  R11845A, exp. date 04 2022  R13271A, exp. date 04 2022  R13648A, exp. date 06 2022  R14101A, exp. date 07 2022  R14667A, exp. date 08 2022  R15953C, exp. date 09 2022"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0627-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Anti-Aging & Wrinkles for Men, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955814726,  NDC 57955-8147-2", "product_quantity": "2060 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 011916C Exp. 01/19; 072716G Exp. 07/19"}, {"country": "United States", "city": "Staten Island", "address_1": "119 Linwood Ave", "reason_for_recall": "Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.", "address_2": "", "product_quantity": "unknown", "code_info": "All Lots", "center_classification_date": "20180228", "distribution_pattern": "NY and NJ through six retail stores named \"Asian Food Markets\"", "state": "NY", "product_description": "HU HU SHENG WEI capsules, 3000 mg, 2-count bottle, labeling is in foreign language", "report_date": "20180207", "classification": "Class I", "openfda": {}, "recalling_firm": "A&H Focal Inc.", "recall_number": "D-0566-2018", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "76644", "termination_date": "20190614", "more_code_info": "", "recall_initiation_date": "20170307", "postal_code": "10305-4445", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0905-2022", "product_description": "Sodium Selenite 200 mg/mL, Multi-Dose 30 mL vial, Rx Only,  Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0074-30", "product_quantity": "2333 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lots: L24014 BUD: 6/14/2022; B24024-22 BUD: 8/24/2022", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BA720563"], "brand_name": ["LMD IN DEXTROSE"], "generic_name": ["DEXTRAN 40"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-7418", "0409-7419"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["DEXTRAN 40"], "rxcui": ["244250"], "spl_id": ["3c902885-18ac-423a-8320-b1998aeefeae"], "spl_set_id": ["3c273512-84e2-2cea-b201-12345a6bd1fe"], "package_ndc": ["0409-7418-13", "0409-7418-03", "0409-7419-14", "0409-7419-03"], "is_original_packager": [true], "nui": ["N0000184175", "N0000009361", "N0000010288"], "pharm_class_epc": ["Plasma Volume Expander [EPC]"], "pharm_class_pe": ["Increased Intravascular Volume [PE]"], "pharm_class_moa": ["Osmotic Activity [MoA]"], "unii": ["K3R6ZDH4DU"]}, "product_type": "Drugs", "event_id": "83947", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States and Puerto Rico", "recall_number": "D-0136-2020", "product_description": "10% LMD in 5% Dextrose Injection Dextran 40 in Dextrose Injection, USP,  500 mL bags, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7418-13", "product_quantity": "17832 bags", "reason_for_recall": "Lack of Assurance of Sterility:  Bag has the potential to leak.", "recall_initiation_date": "20191002", "center_classification_date": "20191009", "termination_date": "20201201", "report_date": "20191016", "code_info": "Lot #: 87-095-JT Exp. 1MAR2020"}, {"status": "Terminated", "city": "Minneapolis", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63354", "recalling_firm": "Paddock Laboratories, LLC", "address_1": "3940 Quebec Ave N", "address_2": "N/A", "postal_code": "55427-1244", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-007-2013", "product_description": "Moexipril HCl Tablets 7.5mg, 100 tabs, Rx Only, Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0110-01 ,", "product_quantity": "2267 bottles", "reason_for_recall": "Paddock Laboratories, LLC are recalling one lot   (2012028142) of Moexipril HCl Tablets 7.5mg (expiration 1/2014) because of a  non-conformity dissolution failure result found during routine stability testing at the 6 month test interval.", "recall_initiation_date": "20121003", "center_classification_date": "20121009", "termination_date": "20131112", "report_date": "20121017", "code_info": "2012028142 exp. 1/2014"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0942-2019", "product_description": "NET Remedies #24 Day & Night Vitals Homeopathic Preparation, Oral Liquid, 57 mL, NDC 57955-4214-2", "product_quantity": "5400 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: NR-031516B Exp. 03/19; NR-021717H Exp. 02/20; NR-050916C Exp. 05/19; NR-061616M Exp. 06/19; NR-090916A Exp. 09/19; NR-101416M Exp. 10/19; NR-120815B Exp. 12/18"}, {"country": "United States", "city": "Raymondville", "address_1": "910 E Hidalgo Ave", "reason_for_recall": "CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.", "address_2": "Suite 3", "product_quantity": "24 bottles", "code_info": "Lot: 23221701, Exp. 05/19", "center_classification_date": "20170911", "distribution_pattern": "TX", "state": "TX", "product_description": "Doctor Manzanilla Allergy & Decongestant Relief  (diphenhydramine hydrochloride and phenylephrine hydrochloride) Syrup, 12.5 mg and 5 mg in each 5 mL, 4 fl oz. (118 mL) bottle, Distributed by: Midvalley Pharmaceuticals, Raymondville, TX  78580, UPC 7 62558 00204 1.", "report_date": "20170920", "classification": "Class II", "openfda": {}, "recalling_firm": "Mid Valley Pharmaceutical", "recall_number": "D-1135-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "78049", "termination_date": "20200507", "recall_initiation_date": "20170830", "postal_code": "78580-4095", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71104", "recalling_firm": "Wockhardt Usa Inc.", "address_1": "20 Waterview Blvd Ste 3", "address_2": "N/A", "postal_code": "07054-1271", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide including Puerto Rico.", "recall_number": "D-1265-2015", "product_description": "Famotodine Tablets, USP, 20 mg Tablets,  Packaged in A) 30 Count Bottles (NDC: 64679-936-01), B) 100 Count Bottles(NDC: 64679-936-02), and C) 1000 Count Bottles (NDC: 64679-936-03), Rx only.  Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA.", "product_quantity": "A) 69,008 Bottles, B) 399,730 Bottles, and C) 58,116 Bottles.", "reason_for_recall": "CGMP Deviations: Firm did not adequately investigate customer complaints.", "recall_initiation_date": "20150422", "center_classification_date": "20150717", "termination_date": "20180509", "report_date": "20150729", "code_info": "A) Lot #:  LM10708, Expiry: 4/30/2015; Lot #: LM10859, Expiry: 5/31/2015; Lot #: LM11200, Expiry: 7/31/2015; Lot #: LM11679, Expiry: 9/30/2015; Lot #: LN10465, Expiry: 1/31/2016; Lot #: LN10750, Expiry: 3/31/2016; Lot #: LN11385, Expiry: 9/30/2016.  B) Lot #: LM10709, Expiry: 4/30/2015; Lot #: LM10719, Expiry: 4/30/2015; Lot #: LM10721, Expiry: 4/30/2015; Lot #: LM10827, Expiry: 5/31/2015; Lot #: LM10828, Expiry: 5/31/2015; Lot #: LM10912, Expiry: 5/31/2015, Lot #: LM11205, Expiry: 7/31/2015; Lot #: LM11206, Expiry: 7/31/2015, Lot #: LM11239. Expiry: 7/31/2015; Lot #: LM11680, Expiry: 9/30/2015; Lot #: LM11822, Expiry: 10/31/2015; Lot #: LM11993, Expiry: 10/31/2015; Lot #: LN10114, Expiry: 12/31/2015; Lot #: LN10115, Expiry: 12/31/2015; Lot #: LN10695, Expiry: 3/31/2016; Lot #: LN10696, Expiry: 3/31/2016; Lot #: LN10697, Expiry: 3/31/2016; Lot #: LN10745, Expiry: 3/31/2016; Lot #: LN10749, Expiry: 3/31/2016; Lot #: LN11249, Expiry: 6/30/2016; Lot #: LN11374, Expiry: 8/31/2016; Lot #: LN11376, Expiry: 8/31/2016; Lot #: LN11382, Expiry: 7/31/2016; Lot #: LN11386, Expiry: 9/30/2016. C) Lot #: LM10685, Expiry: 4/30/2015; Lot #: LM10687, Expiry: 4/30/2015; Lot #: LM10691, Expiry: 4/30/2015; Lot #: LM10692, Expiry: 4/30/2015; Lot #: LM10707, Expiry: 4/30/2015; Lot #: LM10735, Expiry: 4/30/2015; Lot #: LM10741, Expiry: 4/30/2015; Lot #: LM10743, Expiry: 4/30/2015; Lot #: LM10860, Expiry: 5/31/2015; Lot #: LM10861, Expiry: 5/31/2015; Lot #: LM10862, Expiry: 5/31/2015; Lot #: LM10869, Expiry: 5/31/2015; Lot #: LM10911, Expiry: 5/31/2015; Lot #: LM11158, Expiry: 4/30/2015; Lot #: LM12039, Expiry: 10/31/2015; Lot #: LN10426, Expiry: 1/31/2016; Lot #: LN10427, Expiry: 1/31/2016; Lot #: LN10428, Expiry: 1/31/2016; Lot #: LN10435, Expiry: 1/31/2016; Lot #: LN10463, Expiry: 1/31/2016; Lot #: LN10464, Expiry: 1/31/2016; Lot #: LN10674, Expiry: 3/31/2016; Lot #: LN10675, Expiry: 3/31/2016; Lot #: LN10676, Expiry: 3/31/2016; Lot #: LN10751, Expiry: 3/31/2016; Lot #: LN11017, Expiry: 5/31/2016; Lot #: LN11018, Expiry: 5/31/2016; Lot #: LN11023, Expiry: 5/31/2016; Lot #: LN11216, Expiry: 6/30/2016; Lot #: LN11217, Expiry: 6/30/2016; Lot #: LN11391, Expiry: 9/30/2016; Lot #: LN11394, Expiry: 9/30/2016; Lot #: LN11401, Expiry: 9/30/2016; Lot #: LN11408, Expiry: 9/30/2016; Lot #: LN11410, Expiry: 9/30/2016."}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "88145", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0690-2021", "product_description": "Erythromycin Topical Gel, 2%, Net Wt. (a) 30 g,(NDC 52565-033-30) (b) 60 g,(NDC 52565-033-60) Rx Only, Manufactured by: Teligent Pharma, Inc. , Buena, NJ 08310,", "product_quantity": "22,824 tubes", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20210622", "center_classification_date": "20210719", "termination_date": "20240703", "report_date": "20210728", "code_info": "1) NDC 52565-033-30    Lot 14010, Exp July 2021;     2) NDC 52565-033-60    Lot 13865, Exp June 2021; Lot 14011, Exp July 2021.", "more_code_info": ""}, {"status": "Ongoing", "city": "Zagreb", "state": "N/A", "country": "Croatia", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96601", "recalling_firm": "Apipharma", "address_1": "Ulica Jeronima Kavanjina 26", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AZ", "recall_number": "D-0375-2025", "product_description": "Hemopropin Ointment, Lanolin 17.76% and Petrolatum 71.2%, Net Wt. 0.7 oz (20g) tubes, Manufactured by: Apipharma d.o.o, Croatia, Distributed by: Apipharma, LLC, Tempe, AZ  UPC 3 858882 103534 and UPC 3 858882 101318", "product_quantity": "4,218 boxes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250409", "center_classification_date": "20250418", "report_date": "20250430", "code_info": "Lot #: A00001, Exp.: 2027-12; A00005, Exp.: 2027-01; B00001, Exp.:2028-02"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0146-2016", "product_description": "TESTOSTERONE/ANASTROZOLE, Pellet, 200/13 mg, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "60 pellets", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t09262014@23, t07282014@9, t07012014@11, t06092015@8, t05132015@6, t02172015@13, t01232015@7, 07222015@1."}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0844-2023", "product_description": "Sodium Chloride Ophthalmic Ointment, USP, 5%, 3.5g tubes, Manufactured by: Akorn Inc., Lake Forest, IL 60045. ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0085-2016", "product_description": "ESTRADIOL, Pellet, 3 mg,  Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "68 pellets", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t12092014@19, t11252014@18, t09222014@34, t09082014@23, t09052014@11, t08262014@16, t08042014@36, t07022015@34, t06022015@28, t05112015@13, t03302015@22, t03062015@27, t01232015@23, t01022015@16, 10242014@3, 10072014@5."}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Zydus Pharmaceuticals (USA) Inc."], "product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["8a5df7d8-ad17-44d7-9c56-44fa2aaa0852"], "spl_set_id": ["fc2bd95d-a7bc-4ab5-bffa-f5059cb8eb63"], "package_ndc": ["70710-1129-1", "70710-1129-2", "70710-1129-4", "70710-1130-1", "70710-1130-2", "70710-1130-4", "70710-1131-1", "70710-1131-2", "70710-1131-4", "70710-1132-1", "70710-1132-2", "70710-1132-4", "70710-1133-1", "70710-1133-2", "70710-1133-4"], "is_original_packager": [true], "upc": ["0370710112912", "0370710113216", "0370710113018"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97534", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0634-2025", "product_description": "Chlorpromazine Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1131-1", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit", "recall_initiation_date": "20250903", "center_classification_date": "20250910", "report_date": "20250917", "code_info": "Lot #: Z306327, Exp Date 30-11-25; Z306748, Exp Date 30-11-25; Z401154, Exp Date 28-02-26; Z403738, Exp Date 31-05-26; Z405645, Exp Date 30-09-26"}, {"status": "Ongoing", "city": "Texarkana", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M007"], "brand_name": ["MAGNESIUM CITRATE"], "generic_name": ["FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE"], "manufacturer_name": ["Pharma Nobis, LLC"], "product_ndc": ["82645-311"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["MAGNESIUM CITRATE"], "rxcui": ["1052760"], "spl_id": ["0d1c5d55-b64c-8097-e063-6394a90a25ca"], "spl_set_id": ["f0488c86-6c74-3987-e053-2a95a90a31b4"], "package_ndc": ["82645-311-10"], "is_original_packager": [true], "upc": ["0382645311100"], "unii": ["RHO26O1T9V"]}, "product_type": "Drugs", "event_id": "93682", "recalling_firm": "Pharma Nobis LLC", "address_1": "7400 Alumax Rd", "address_2": "N/A", "postal_code": "75501-0282", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide.", "recall_number": "D-0230-2024", "product_description": "Freskaro refresh & revitalize Magnesium Citrate Saline Laxative Oral Solution Grape Flavor 10 fl. oz, Manufactured by: Pharma Lobis, 7400 Alumax Dr., Texarkana, TX 75501, NDC 82645-311-10.", "product_quantity": "53,268 Bottles", "reason_for_recall": "MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.", "recall_initiation_date": "20231221", "center_classification_date": "20240112", "report_date": "20240124", "code_info": "Lot A80553; Exp. 11/2025"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "38 doses", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #s: 10092013@4, 10162013@1", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "Combo Eye Gel, HF COMBO EYE GEL* (cyclopentolate 2%, tropicamide 1%, diclofenac sodium 0.1%, ciprofloxacin 0.3%, phenylephrine 10%, lidocaine jelly 2%), Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI  48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-414-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88384", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0335-2022", "product_description": "CVS Allergy Relief, Fexofenadine Hydrochloride Tablets, 60 mg Antihistamine,  12HR, packaged as a) 12 count bottle, NDC 59779-425-53, UPC 0 50428 25414 1; b)24 count bottle, NDC 59779-425-62, UPC 0 50428 53435 9; Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895, Made in Czech Republic", "product_quantity": "138,144 containers", "reason_for_recall": "Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.", "recall_initiation_date": "20210727", "center_classification_date": "20220105", "termination_date": "20221108", "report_date": "20220112", "code_info": "Lot # a) 0ME2516, Exp 4/30/2022 b)0ME2515, Exp 4/30/2022; 0KE2982, Exp 1/31/2022"}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1000 mL in Vials", "code_info": "Lot #: 160118-31, BUD: 07/16/16", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "METHYL B12 10MG/ML (PF) IN NACL 0.9%, 1ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1216-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Nicholasville", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89909", "recalling_firm": "TMC Acquisition LLC dba Tailor Made Compounding", "address_1": "200 Moore Dr", "address_2": "", "postal_code": "40356-8512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1222-2022", "product_description": "Procaine HCL 2% (20mg/mL), 30 ml-vial, Refrigerate, Tailor Made Compounding", "product_quantity": "58 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220307", "center_classification_date": "20220714", "report_date": "20220720", "code_info": "Batch#: 10112102A2, Exp 4/9/2022; 11302101A1, Exp 5/29/2022; 01242201A1, Exp 5/31/2022.", "more_code_info": ""}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96191", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL", "recall_number": "D-0217-2025", "product_description": "Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC: 70518-3945-00.", "product_quantity": "247 blister packs", "reason_for_recall": "CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.", "recall_initiation_date": "20250124", "center_classification_date": "20250203", "termination_date": "20250717", "report_date": "20250212", "code_info": "Lot #s: J0777493050824, Exp. 5/31/2025; J0787856062124, Exp. 7/31/2025.", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1063-2023", "product_description": "fentaNYL in 0.9% sodium chloride, 5000 mcg/250 mL, (20 mcg/mL), 250 mL Bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2074-1", "product_quantity": "1,044 bags", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-271115, Exp. 7/25/2023; 17-271398, Exp. 7/30/2023; 17-272278, Exp. 8/14/2023; 17-272449, Exp. 8/16/2023; 17-272521, Exp. 8/17/2023; 17-272900, Exp. 8/23/2023; 17-273146, Exp. 8/29/2023; 17-273236, Exp. 8/30/2023; 17-273404, Exp. 9/3/2023; 17-273678, Exp. 9/6/2023; 17-273954, Exp. 9/11/2023; 17-274213, Exp. 9/14/2023."}, {"status": "Terminated", "city": "Southern Pines", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70656", "recalling_firm": "Health Innovations Pharmacy, Inc", "address_1": "295 Pinehurst Ave Bldg 2", "address_2": "N/A", "postal_code": "28387-7051", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "NC", "recall_number": "D-1015-2015", "product_description": "Naltrexone 4.5 mg Caps, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.", "recall_initiation_date": "20150212", "center_classification_date": "20150508", "termination_date": "20170720", "report_date": "20150520", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63384", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-030-2013", "product_description": "Premier Value Fiber Capsules, Fiber Capsules, 100% Natural Psyllium Fiber, Relieves Constipation, Restores Regularity, 160 Capsules per bottle, Distributed by: Chain Drug Consortium, LLC, Boca Raton, FL 33431, UPC0-40986-01703-2", "product_quantity": "1,440 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.", "recall_initiation_date": "20120904", "center_classification_date": "20121025", "termination_date": "20141007", "report_date": "20121031", "code_info": "Lot 16470, Exp 08/15"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-263-2014", "product_description": "Sermorelin 6mg, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "706 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1150-2020", "product_description": "Phlegm Off, 500mg Capsules, 90-count bottles, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1429-2022", "product_description": "MIRALAX 8.3 OZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKU: 902219", "more_code_info": ""}, {"status": "Terminated", "city": "Davie", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77960", "recalling_firm": "Pharmatech LLC", "address_1": "4131 SW 47th Ave Ste 1403", "address_2": "N/A", "postal_code": "33314-4036", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MI", "recall_number": "D-0227-2018", "product_description": "Rugby Aller-chlor (Chlorpheniramine Maleate Syrup, USP), 2 mg, 4 fl. oz. (120 mL) plastic bottles, Distributed by: Rugby Laboratories 17177 N. Laurel Park Drive, Suite 233, Livonia, MI 48152 USA --- NDC: 0536-1025-47, Manufactured by PharmaTech LLC, Davie FL", "product_quantity": "Unknown", "reason_for_recall": "Microbial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contamination", "recall_initiation_date": "20170816", "center_classification_date": "20180117", "termination_date": "20230104", "report_date": "20180124", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0049-2019", "product_description": "QC Quality Choice, Saline Nasal Gel with Soothing Aloe, 0.5 OZ (14.1 g) tube, Distributed by C.D.M.A., Inc., 43157 W. Nine Mile, Novi, MI 48376-0995, UPC 6 35515 99202 3.", "product_quantity": "4,200 tubes", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0524-2018", "product_description": "Tadalafil USP (Monohydrate) for prescription compounding, packaged  in a) 5g (NDC 58597-8538-2); b) 25g (NDC 58597-8538-4); c)100g (NDC 58597-8538-6); d) 500g (NDC 58597-8538-7); d) 1000g (NDC 58597-8538-8), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "90000 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 020717-3, Exp. 12/31/2021; b) 020717-2  020717-4, 020717-5 Exp. 12/31/2021; 092816-2,  092816-3,  Exp. 07/31/2021; 121015-4, 121015-5, 121015-6, Exp.10/31/2020; c) 020717-1,   020717-4, 020717-5, Exp. 12/31/2021; 092816-1, Exp. 07/31/2021;  092816-2, Exp. 07/31/2021; 121015-1,121015-3, Exp. 10/31/2020; d) 020717-1, 020717-2, Exp. 12/31/2021; 092816-1, Exp. 07/31/2021;  121015-2, Exp. 10/31/2020; e) 020717-1,020717-2  Exp. 12/31/2021."}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74187", "recalling_firm": "Well Care Compounding Pharmacy", "address_1": "3430 E Tropicana Ave Ste 9", "address_2": "N/A", "postal_code": "89121-7345", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "NV", "recall_number": "D-1025-2016", "product_description": "QUAD-MIX #3, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121", "product_quantity": "869 Units (Total All Products)", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.", "recall_initiation_date": "20160517", "center_classification_date": "20160609", "termination_date": "20170113", "report_date": "20160615", "code_info": "Lot #: 011520J6:90@35, Exp.04/17/2016; Lot #: 04282016:23@31, Exp.08/01/2016."}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018449"], "brand_name": ["INTRALIPID"], "generic_name": ["I.V. FAT EMULSION"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0519"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SOYBEAN OIL"], "rxcui": ["200317", "805127", "1799694", "1799696", "1799704", "1799706", "1799724", "1799725"], "spl_id": ["a34dffef-567f-47fe-9f33-3370819874c8"], "spl_set_id": ["a69c82da-15ba-4d4d-8d7f-871dc3981eb8"], "package_ndc": ["0338-0519-58", "0338-0519-09", "0338-0519-13"], "is_original_packager": [true], "nui": ["N0000191261", "M0012553"], "pharm_class_epc": ["Lipid Emulsion [EPC]"], "pharm_class_cs": ["Lipids [CS]"], "unii": ["241ATL177A"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1119-2022", "product_description": "Intralipid (I.V. Fat emulsion), 20%, 250 mL bag, Rx only, MFG: Baxter Healthcare, NDC 0338-0519-09", "product_quantity": "5 cases", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Ongoing", "city": "Athens", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95826", "recalling_firm": "Midlab Incorporated", "address_1": "140 Private Brand Way", "address_2": "", "postal_code": "37303-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0090-2025", "product_description": "ROYALAB Germ Away Antibacterial Hand Soap, Chloroxylenol 0.1%, NET CONTENTS: ONE U.S. GALLON (3.78 L), Royal Papers, 2701 Hereford St., St. Louis, MO 63139", "product_quantity": "", "reason_for_recall": "cGMP Deviations: Out of specification results for micro in hand soap products.", "recall_initiation_date": "20241106", "center_classification_date": "20241202", "report_date": "20241211", "code_info": "Lot 0711241", "more_code_info": ""}, {"status": "Terminated", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90886", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "N/A", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1542-2022", "product_description": "Ampicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vials per carton NDC 67457-352-10, Rx only, Mylan Manufactured in India for: Mylan Institutional LLC Rockford, IL 61103 U.S.A", "product_quantity": "3,931 cartons", "reason_for_recall": "Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.", "recall_initiation_date": "20220921", "center_classification_date": "20220923", "termination_date": "20231031", "report_date": "20221005", "code_info": "Lot 7105130, exp 9/2023"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-804-2015", "product_description": "Mitotane active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "21500 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M012"], "brand_name": ["MUCINEX FAST-MAX"], "generic_name": ["ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE"], "manufacturer_name": ["RB Health (US) LLC"], "product_ndc": ["63824-015"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN", "DEXTROMETHORPHAN HYDROBROMIDE", "GUAIFENESIN", "PHENYLEPHRINE HYDROCHLORIDE"], "rxcui": ["1116572"], "spl_id": ["3cbcc048-bbed-a3e5-e063-6394a90aed10"], "spl_set_id": ["c902b4fc-c71c-4ef2-b5cb-6c2bd019acbc"], "package_ndc": ["63824-015-66", "63824-015-69"], "is_original_packager": [true], "upc": ["0363824015651"], "nui": ["N0000193956", "N0000008867", "N0000009560"], "pharm_class_epc": ["Expectorant [EPC]"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "unii": ["362O9ITL9D", "9D2RTI9KYH", "495W7451VQ", "04JA59TNSJ"]}, "product_type": "Drugs", "event_id": "71013", "recalling_firm": "Reckitt Benckiser LLC", "address_1": "399 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1133", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1363-2015", "product_description": "Mucinex Fast Max Cold, Flu & Sore Throat, Maximum Strength, Acetaminophen Pain Reliever/Fever Reducer, Dextromethorphan HBr Cough Suppressant, Guaifenesin Expectorant, Phenylephrine HCl Nasal Decongestant, 6 fl oz (180 mL) Bottle, For Ages 12+, , Dist. By: Reckitt Benckiser Parsippany, NJ 07054-0224 Made in India, NDC 63824-015-66, UPC 63824-01565-1", "product_quantity": "495036 Bottles", "reason_for_recall": "Labeling: Label Mix-Up; Bottles of Mucinex Fast-Max liquid are correctly labeled on the front of the label, however the back of the bottle where the Drug Facts labeling is, is missing certain Active Ingredients such as acetaminophen, phenylephrine, dextromethorphan, diphenhydramine, and/or guaifenesin. As a result certain safety warnings associated with those ingredients may also be missing.", "recall_initiation_date": "20150415", "center_classification_date": "20150825", "termination_date": "20180309", "report_date": "20150902", "code_info": "Lot #:           Exp:   MCF0048 7/31/2016  MCF0051 7/31/2016  MCF0052 8/31/2016  MCF0053 8/31/2016  MCF0054 8/31/2016  MCF0055 8/1/2016  MCF0056 8/31/2016  MCF0057 8/31/2016  MCF0058 8/31/2016  MCF0059 10/1/2016  MCF0060 8/31/2016  MCF0061 8/31/2016  MCF0062 8/31/2016  MCF0063 9/30/2016  MCF0064 9/30/2016  MCF0065 9/30/2016  MCF0066 9/30/2016  MCF0067 9/30/2016  MCF0068 9/30/2016  MCF0069 10/31/2016  MCF0070 10/31/2016  MCF0071 10/31/2016  MCF0072 10/31/2016  MCF0073 10/31/2016  MCF0074 10/31/2016  MCF0075 10/31/2016  MCF0076 10/31/2016  MCF0077 10/31/2016"}, {"country": "United States", "city": "Rockford", "address_1": "4901 Hiawatha Dr", "reason_for_recall": "Presence of Particulate Matter", "address_2": "", "product_quantity": "4,445 vials", "code_info": "Lot #: 7801312, Exp 06/15", "center_classification_date": "20150814", "distribution_pattern": "Nationwide", "state": "IL", "product_description": "CARBOplatin Injection 450 mg/45 mL (10 mg/mL), 45 mL packaged in a 100 mL Multi-Dose Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL  61103, Made in India, NDC 67457-493-46, UPC 3 67457 49346 6.", "report_date": "20150826", "classification": "Class I", "openfda": {}, "recalling_firm": "Mylan Institutional LLC", "recall_number": "D-1331-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "70991", "termination_date": "20160519", "more_code_info": "", "recall_initiation_date": "20150318", "postal_code": "61103-1287", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Little Rock", "address_1": "8821 Knoedl Ct", "reason_for_recall": "Subpotent Drug: Stability data does not support the current expiration dating of 55 days after compounding.", "address_2": "", "product_quantity": "3984 syringes", "code_info": "Lot #: 20180507@21, Exp 7/1/2018; 20180511@9, 20180511@24, Exp 7/5/2018; 20180518@24, 20180518@31, 20180518@32, Exp 7/12/2018; 20180531@21, Exp 7/25/2018; 20180601@11, Exp 7/26/2018", "center_classification_date": "20180712", "distribution_pattern": "United States", "state": "AR", "product_description": "Buffered Lidocaine 1% with Sodium Bicarbonate Injection for Local Anesthetic Use (Concentration=10 mg/mL) 0.25 mL Total Volume, Rx only , SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205 877-550-5059", "report_date": "20180718", "classification": "Class II", "openfda": {}, "recalling_firm": "SCA Pharmaceuticals", "recall_number": "D-0918-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80425", "termination_date": "20190501", "more_code_info": "", "recall_initiation_date": "20180629", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Phoenix", "address_1": "24416 N 19th Ave", "reason_for_recall": "Lack of Assurance of Sterility: Potential leakage of bags.", "address_2": "", "product_quantity": "120 syringes", "code_info": "Lot # 5/3/18 0317 142-21070S, BUD 8/1/2018; 5/10/18 0512 144-21070S, BUD 8/8/2018; 6/1/18 0305 142-21070S , BUD 8/30/2018; 6/4/18 0505 252-21070S, BUD 9/2/2018.", "center_classification_date": "20180719", "distribution_pattern": "Nationwide in the USA", "state": "AZ", "product_description": "fentaNYL (10 mcg per mL) in 0.95 Sodium Chloride, USP QS 1mL. Volume 1mL. Single dose Syringe. For: Hunt Regional Medical Center, By: Advanced Pharma, 9265 Kirby Dr,., Houston, TX 77054.  NDC 15082-210-70", "report_date": "20180725", "classification": "Class II", "openfda": {}, "recalling_firm": "Avella of Deer Valley, Inc. Store 38", "recall_number": "D-0933-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80307", "termination_date": "20200124", "more_code_info": "", "recall_initiation_date": "20180612", "postal_code": "85085-1887", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68453", "recalling_firm": "Actavis Inc", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-1386-2014", "product_description": "Vancomycin Hydrochloride Capsules, USP, 250 mg.  20 Capsules on 2 x 10 Capsule Blister Cards, Rx Only. Mfd. for: Watson Pharma Inc., Parsippany, NJ 07054 USA. Mfd. by: Patheon Pharmaceuticals Inc., Cincinnati, OH 45237 USA. NDC 0591-3561-15.", "product_quantity": "6913 packages", "reason_for_recall": "Subpotent Drug.", "recall_initiation_date": "20140516", "center_classification_date": "20140617", "termination_date": "20150223", "report_date": "20140625", "code_info": "Lot #: 3100135, Expiry: 05/2014", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0119-2022", "product_description": "IC B COMPLEX INJ  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 09152021:12 BUD: 12/14/2021", "more_code_info": ""}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "430 vials and syringes", "code_info": "Lot #: a) Methylpred/ Dexameth 1-2-3 mL: 13040150GV1, Exp 7/1/2013; 13032750GV3, Exp 6/27/2013; b) Methylpred/Dexa 3 mL PFS: 13032050GV4, Exp 6/20/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Methylprednisolone and Dexamethasone Injection, all strengths and all presentations including a) Methylpred/ Dexameth 1-2-3 mL and b) Methylpred/Dexa 3 mL PFS; Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-389-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "597 vials", "code_info": "Lot #: 20130122-C, Exp 4/22/2013; 20130122-D, Exp 4/22/2013; 20130319-A, Exp 6/19/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Bacteriostatic Water for Injection, all presentations including 30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-344-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-092-2014", "product_description": "Estradiol Pellets 15mg, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "19 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "93178", "recalling_firm": "Denver Solutions, LLC DBA Leiters Health", "address_1": "13796 Compark Blvd", "address_2": "N/A", "postal_code": "80112-7145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0072-2024", "product_description": "VANCOmycin HCI PF, 1.5 g added to 0.9% Sodium Chloride 250 mL IV Bag, Rx only, Leiters Compounding Health, 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-029-68.", "product_quantity": "25,908 IV bags", "reason_for_recall": "Labeling: Not Elsewhere Classified", "recall_initiation_date": "20231004", "center_classification_date": "20231026", "termination_date": "20240815", "report_date": "20231101", "code_info": "Lot#: 2330792, Exp. 12/17/23; 2330801, Exp. 12/26/23; 2330821, 10/15/23; 2330823, Exp. 10/21/23; 2330825, Exp. 10/27/23; 2330846, Exp. 10/28/23; 2330847, Exp. 11/03/23; 2330856, 11/17/23; 2330858, Exp. 12/03/23; 2330860, 12/15/23; 2330866, Exp. 12/29/23; 2331053, Exp. 01/13/24."}, {"status": "Terminated", "city": "Cedar Park", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "65953", "recalling_firm": "Specialty Compounding, LLC", "address_1": "211 South Bell (Hwy 183 N)", "address_2": "N/A", "postal_code": "78613", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0230-2015", "product_description": "CALCIUM GLUCONATE 2 gm (PF) PRESERVATIVE FREE in 100 mL Sodium Chloride 0.9% for Injection, Rx Only Manufactured by Specialty Compounding, 211 S. Bell Blvd, Cedar Park, TX 78613", "product_quantity": "Undetermined", "reason_for_recall": "Non Sterility: Microbial contamination", "recall_initiation_date": "20130809", "center_classification_date": "20141030", "termination_date": "20160922", "report_date": "20141105", "code_info": "Lot #: 07092013M16; Exp 09/13", "more_code_info": ""}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "10", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Diltiazem HCI 250 mg in 5% Dextrose, 250 mL lntravia bag, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0853-02", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1309-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0357-2017", "product_description": "Forskolin/PAPAV/PHEN/PGE1, 100 mcg/30 mcg/3 mcg/60 mcg/mL, 5 mL vial, Injectable, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "22 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 05272016@18."}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "65747", "recalling_firm": "Watson Laboratories Inc", "address_1": "132 Business Center Dr", "address_2": "N/A", "postal_code": "92880-1724", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-823-2013", "product_description": "Oxycodone and Acetaminophen Capsules, USP 5mg/500 mg, packaged in a)100-count bottle (NDC 0591-0737-01), b) 500-count bottle (NDC 0591-0737-05), Rx only, Manufactured by Watson Laboratories, Inc., Corona, CA92880.", "product_quantity": "1,260 bottles", "reason_for_recall": "Subpotent drug: Two lots of Oxycodone and Acetaminophen Capsules, USP 5/500 mg are being recalled due to low out of specification (OOS) assay result obtained at expiry (24 months) for the oxycodone portion of the product.", "recall_initiation_date": "20130719", "center_classification_date": "20130725", "termination_date": "20140729", "report_date": "20130731", "code_info": "Lot # a) 444971A, Exp 8/13; b) 444973A, Exp 8/13", "more_code_info": ""}, {"status": "Terminated", "city": "San Francisco", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73662", "recalling_firm": "Reliable Rexall-A Compounding Pharmacy", "address_1": "801 Irving St", "address_2": "N/A", "postal_code": "94122-2310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Including: CA, HI, NM", "recall_number": "D-1096-2016", "product_description": "All Jack Newman Cream Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.", "product_quantity": "N/A", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20160325", "center_classification_date": "20160706", "termination_date": "20170410", "report_date": "20160713", "code_info": "All lots compounded between 03/24/2015 and 03/24/2016 and within expiry."}, {"status": "Terminated", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74822", "recalling_firm": "Safecor Health, LLC", "address_1": "317 New Boston St", "address_2": "N/A", "postal_code": "01801-6231", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MA and NY", "recall_number": "D-0902-2017", "product_description": "Calcium Carbonate 600mg/Vitamin D3 400 International Units tablets, 60-count bottles,  Pk By Safecor Health Woburn, MA 01801, NDC 00904323392.", "product_quantity": "25 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20160707", "center_classification_date": "20170612", "termination_date": "20170712", "report_date": "20170621", "code_info": "Lot # A18705, Exp. 09/30/2017"}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0497-2022", "product_description": "Pain & Sinus Reliever Pain Reliever/Nasal Decongestant (acetaminophen 500mg, Phenylephrine HCl 5mg) 2 tablet packets, Mfg for Advanced First Aid, Baltimore, MD 21237, NDC 67060-194-68", "product_quantity": "887,000 packets", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: AK9527, Exp. Date 03/2022"}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83025", "recalling_firm": "Sun Pharmaceutical Industries, Inc.", "address_1": "270 Prospect Plains Rd", "address_2": "N/A", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1388-2019", "product_description": "Allergy Relief D, Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg,   Extended Release Tablets, USP, 20-count box, Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895. Made in India.   UPC 0 50428 43023 1", "product_quantity": "17,136 20-count units", "reason_for_recall": "Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit", "recall_initiation_date": "20190605", "center_classification_date": "20190614", "termination_date": "20210108", "report_date": "20190626", "code_info": "Lot GKT0791, EXP 06/2020"}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA078525"], "brand_name": ["LAMOTRIGINE"], "generic_name": ["LAMOTRIGINE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["51672-4130", "51672-4131", "51672-4132", "51672-4133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LAMOTRIGINE"], "rxcui": ["198427", "198428", "198429", "282401"], "spl_id": ["4148a175-3297-0339-e063-6294a90a2ffb"], "spl_set_id": ["b829f9b2-f0ac-408a-a6f4-18b72150227d"], "package_ndc": ["51672-4130-6", "51672-4130-4", "51672-4130-1", "51672-4130-3", "51672-4130-0", "51672-4131-6", "51672-4131-4", "51672-4131-1", "51672-4131-3", "51672-4131-0", "51672-4132-6", "51672-4132-4", "51672-4132-1", "51672-4132-2", "51672-4132-3", "51672-4132-0", "51672-4133-6", "51672-4133-4", "51672-4133-1", "51672-4133-2", "51672-4133-3", "51672-4133-0"], "is_original_packager": [true], "upc": ["0351672413019", "0351672413347", "0351672413248", "0351672413118"], "nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "unii": ["U3H27498KS"]}, "product_type": "Drugs", "event_id": "84645", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S. and Puerto Rico.", "recall_number": "D-0833-2020", "product_description": "Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle,  Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4131-1.", "product_quantity": "", "reason_for_recall": "Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.", "recall_initiation_date": "20191220", "center_classification_date": "20200207", "termination_date": "20240223", "report_date": "20200219", "code_info": "Lot #: 331771, Exp. June 2021", "more_code_info": ""}, {"status": "Terminated", "city": "Atlanta", "state": "GA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA206368"], "brand_name": ["TESTOSTERONE CYPIONATE"], "generic_name": ["TESTOSTERONE CYPIONATE"], "manufacturer_name": ["Wilshire Pharmaceuticals"], "product_ndc": ["52536-625"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["TESTOSTERONE CYPIONATE"], "rxcui": ["835840", "2047882"], "spl_id": ["3ab32628-1fbc-e980-e063-6394a90a81c4"], "spl_set_id": ["58ff6e0d-cc0a-4455-8254-d883d26a3b6d"], "package_ndc": ["52536-625-01", "52536-625-10"], "is_original_packager": [true], "unii": ["M0XW1UBI14"]}, "product_type": "Drugs", "event_id": "83959", "recalling_firm": "Arbor Pharmaceuticals Inc.", "address_1": "6 Concourse Pkwy Ste 1800", "address_2": "", "postal_code": "30328-5353", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0167-2020", "product_description": "Testosterone Cypionate Injection, USP, 2000 mg/10 mL, 1 mL Vial, Single-Dose,  Rx only, Mfd. for: Wilshire Pharmaceuticals, Inc. Atlanta, GA 30328. NDC 52536-625-01", "product_quantity": "67934 units", "reason_for_recall": "Labeling:Label Mix-up: Shipper Carton labelled Testosterone Cypionate Injection, USP, 200mg/mL, 1 ml single-dose  vials, found to contain shelf cartons labelled as Testosterone Cypionate Injection USP, 200mg/mL, 10 ml  multi-dose vials which contain Testosterone Cypionate Injection USP, 200mg/mL,1mL single-does vials", "recall_initiation_date": "20190927", "center_classification_date": "20191030", "termination_date": "20210202", "report_date": "20191106", "code_info": "lot# 23803.002B, Exp 07/2020; 23803.005A, Exp  01/2021", "more_code_info": ""}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Ropi/ Epi/ Clon PeriCapsular injection all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0801-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1075-2023", "product_description": "midazolam in dextrose 5%, 50 mg /50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-4036-1", "product_quantity": "621 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270666, Exp. 7/18/2023; 17-270879, Exp. 7/20/2023; 17-271669, Exp. 8/2/2023; 17-272287, Exp. 8/14/2023; 17-272366, Exp. 8/15/2023; 17-272991, Exp. 8/24/2023; 17-273512, Exp. 9/4/2023."}, {"country": "United States", "city": "Bridgewater", "address_1": "55 Corporate Dr", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "address_2": "", "product_quantity": "", "code_info": "all lots", "center_classification_date": "20191201", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Cool Mint Tablets Maximum Strength Zantac 150 mg Sanofi Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219.    NDC's:    0597-0120-06,   0597-0120-08,   0597-0120-09,   0597-0120-24,   0597-0120-38,   0597-0120-50,   0597-0120-76,   0597-0120-78,   0597-0120-80,   0597-0120-82,   0597-0120-87.", "report_date": "20191211", "classification": "Class II", "openfda": {}, "recalling_firm": "Sanofi-Aventis U.S. LLC", "recall_number": "D-0534-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84122", "more_code_info": "", "recall_initiation_date": "20191022", "postal_code": "08807-1265", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "San Francisco", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73662", "recalling_firm": "Reliable Rexall-A Compounding Pharmacy", "address_1": "801 Irving St", "address_2": "N/A", "postal_code": "94122-2310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Including: CA, HI, NM", "recall_number": "D-1109-2016", "product_description": "All sulfapyridine Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.", "product_quantity": "N/A", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20160325", "center_classification_date": "20160706", "termination_date": "20170410", "report_date": "20160713", "code_info": "All lots compounded between 03/24/2015 and 03/24/2016 and within expiry."}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85756", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1315-2020", "product_description": "Olanzapine Tablets, USP 7.5 mg, 30-count bottle, Rx only, Manufactured for: Prasco Laboratories Mason, OH 45040 USA, Manufactured by: Aurolife Pharma LLC Dayton, NJ 08810, NDC 66993-682-30", "product_quantity": "7547 bottles", "reason_for_recall": "Failed Impurities/ Degradation Specifications", "recall_initiation_date": "20200526", "center_classification_date": "20200617", "termination_date": "20230110", "report_date": "20200624", "code_info": "Lot #: 563180012A1, Exp 8/2020", "more_code_info": ""}, {"country": "United States", "city": "Newbury Park", "address_1": "914 Tourmaline Drive", "reason_for_recall": "Marketed without an approved NDA/ANDA: INK-EEZE Tattoo Numbing Spray contains 5% Lidocaine and is being marketed without an approved NDA/ANDA. Lidocaine 5% is an ingredient in many FDA approved products, making Ink-Eeze an unapproved new drug.", "address_2": "", "product_quantity": "2849 Bottles", "code_info": "Lot #: L0211", "center_classification_date": "20130627", "distribution_pattern": "California and Colorado.", "state": "CA", "product_description": "INK-EEZE Tattoo Black Label Numbing Spray, a) 0.27 oz. (8 mL), b) 2 oz. (59 mL), No Epinephrine, Active Ingredients: Lidocaine HCl 5% Topical Anesthetic, Distributed by: Indelicare, LLC 914 Tourmaline Drive, Newbury Park, CA 91320, (800) 611-7720, www.inkeeze.com.", "report_date": "20130703", "classification": "Class II", "openfda": {}, "recalling_firm": "Indelicare LLC", "recall_number": "D-622-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "65284", "termination_date": "20140630", "more_code_info": "", "recall_initiation_date": "20130523", "postal_code": "91320", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Stuart", "address_1": "2580 Se Willoughby Blvd", "reason_for_recall": "Marketed without an Approved NDA/ANDA.", "address_2": "", "product_quantity": "316,464 kits", "code_info": "Product Number (s): 60010, 40201, 40202, 40203, 40204, 40205, 40206.", "center_classification_date": "20140131", "distribution_pattern": "Nationwide and Puerto Rico", "state": "FL", "product_description": "Cornea Coat, Hydroxypropylmethylcellulose, 1.5ml Syringe,  Rx Only. Manufactured by: Insight Instruments, Inc., 2580 SE Willoughby  Blvd., Stuart, FL 34994, USA. Tel: 772-219-9393.", "report_date": "20140212", "classification": "Class II", "openfda": {}, "recalling_firm": "Insight Instruments, Inc.", "recall_number": "D-1056-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "65107", "termination_date": "20170502", "more_code_info": "", "recall_initiation_date": "20130424", "postal_code": "34994-4701", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Edmond", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77064", "recalling_firm": "Qualgen", "address_1": "14844 Bristol Park Blvd", "address_2": "N/A", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0894-2017", "product_description": "Estradiol 12.5 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF in 1 count, 12 count, and 30 count bottles, Sterile Office Use Only, For Subcutaneous Use Only, Rx Only, Manufactured by: Qualgen 14844 Bristol Park Blvd Edmond, OK 73013, NDC: 69761-012-01", "product_quantity": "4,883 pellets.", "reason_for_recall": "CGMP deviations- Lack of Quality Assurance", "recall_initiation_date": "20170419", "center_classification_date": "20170607", "termination_date": "20210924", "report_date": "20170614", "code_info": "Lot# C044; Exp. 03/14/18  Lot# C013; Exp. 07/23/17   Lot# B150; Exp. 12/6/17  Lot# B119; Exp. 10/18/17  Lot# B097; Exp. 09/14/17  Lot# B061; Exp. 07/5/17"}, {"country": "United States", "city": "Orchard Park", "address_1": "707 Sterling Drive", "reason_for_recall": "Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due to concerns related to the quality assurance of sterility controls.", "address_2": "", "product_quantity": "", "code_info": "Stock No: 1099; Case UPC: 3 10742 91099 (5); Item UPC 3 10742 01099 2", "center_classification_date": "20140128", "distribution_pattern": "Nationwide and Puerto Rico", "state": "NY", "product_description": "ROHTO Cooling Eye Drops, Itch Relief, Soothes Itch & Burn, relief, Astringent, Lubricant, Redness Reliever Eye Drops, Sterile, Net. Wt. 0.4 FL OZ (13 mL).  UPC 3 10742  01099 2,  Manufactured by Rohto-Mentholatum (Vietnam) Co., Ltd. for The Mentholatum Company, Orchard Park, NY 14127.   Made in Vietnam.", "report_date": "20140205", "classification": "Class II", "openfda": {}, "recalling_firm": "The Mentholatum Co.", "recall_number": "D-1040-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "67314", "termination_date": "20180601", "more_code_info": "", "recall_initiation_date": "20140116", "postal_code": "14127", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; diphenhydrAMINE HCl, Tablet, 25 mg may be potentially mislabeled as     ATORVASTATIN CALCIUM, Tablet, 40 mg, NDC 00378212177, Pedigree: AD33897_10, EXP: 5/9/2014;  ATORVASTATIN CALCIUM, Tablet, 10 mg, NDC 00378201577, Pedigree: W002774, EXP: 6/6/2014;  PRENATAL MULTIVITAMIN/ MULTIMINERAL, Tablet, NDC 51991056601, Pedigree: W003511, EXP: 6/21/2014;  VENLAFAXINE, Tablet, 25 mg", "address_2": "", "product_quantity": "901 Tablets", "code_info": "diphenhydrAMINE HCl, Tablet, 25 mg has the following codes    Pedigree: AD33897_13, EXP: 5/9/2014;  Pedigree: W002775, EXP: 6/6/2014;  Pedigree: W003513, EXP: 6/21/2014;  Pedigree: AD67992_4, EXP: 5/28/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "diphenhydrAMINE HCl, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00904555159", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-483-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Peoria", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72241", "recalling_firm": "Kalman Health & Wellness, Inc. dba Essential Wellness Pharma", "address_1": "4625 N University St", "address_2": "N/A", "postal_code": "61614-5828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-304-2016", "product_description": "DUAL TEST CYP/ENA 1:1 200 mg/mL Injection, packaged in a) 5 mL and b) 100 mL vials, Rx only, Essential Wellness PHARMACY, 4625 N. University, Peoria, IL 61614.", "product_quantity": "a) 720 vials; b) 4 vials", "reason_for_recall": "Lack of Assurance of Sterility:  A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.", "recall_initiation_date": "20150903", "center_classification_date": "20151117", "termination_date": "20171229", "report_date": "20151125", "code_info": "Lot #: 060815, Exp 09/08/2015; 061615, Exp 09/16/2015; 062915, Exp 09/29/2015; 070615, Exp 10/06/2015; 071615, Exp 10/16/2015; 073015, Exp 10/30/2015; and 080615, Exp 11/08/2015"}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0281-2023", "product_description": "CEFOXITIN (a) 1GM IN NS 50ML,(b) 2GM IN NS 100ML, used with a home pump. Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320,", "product_quantity": "3 bags", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use date December 30, 2022"}, {"status": "Ongoing", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95944", "recalling_firm": "Akron Pharma, Inc.", "address_1": "373 Us Highway 46 Ste 117", "address_2": "", "postal_code": "07004-2456", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0195-2025", "product_description": "Acetaminophen, 325 mg Tablets, 100 Tablets per bottle, Akron Pharma, Manufactured for: Akron Pharma Inc., Fairfield, NJ 07034, NDC 71399-8014-01.", "product_quantity": "14825 bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.", "recall_initiation_date": "20241212", "center_classification_date": "20250110", "report_date": "20250122", "code_info": "Lot #s: KDT0124004, KDT0124005, KDT0124006, Exp 08/31/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72746", "recalling_firm": "Sentara Enterprises", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S. Including: VA, NC", "recall_number": "D-0620-2016", "product_description": "Dextrose-NaCl (D5-1/2NS) in NS, Packaged in  a) 1700ML Homepumps, b) 1800ML Homepumps, and c) 1920ML Homepumps, Rx Only. SENTARA HOME HEALTH SENTARA RX, 535 Independence Pkwy ste.300, Chesapeake, VA 23320-5176.", "product_quantity": "a) 1 Bag b) 7 Bags c) 8 Bags", "reason_for_recall": "Lack of Assurance of Sterility: Product sterility cannot be guaranteed.", "recall_initiation_date": "20150918", "center_classification_date": "20160128", "termination_date": "20160629", "report_date": "20160203", "code_info": "All Lots compounded between 11-Sep-15 and 17-Sep-15. Expiries: a) 25-Sep-15, b) 30-Sep-15, c) 28-Sep-15, 1-Oct-15"}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1205-2020", "product_description": "Paregoric Compound (contains Morphine) Solution 480 mL bottle, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 bottle", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45161 Discard by: 5/4/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-816-2015", "product_description": "Nevirapine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "100 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Garner", "address_1": "1027 Us Highway 70 W", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil, making AMPD GOLD an unapproved drug.", "address_2": "Suite 227", "product_quantity": "150 bottles", "code_info": "Lots: ALL", "center_classification_date": "20150504", "distribution_pattern": "WV who distributed Nationwide.", "state": "NC", "product_description": "AMPD GOLD Bee Pollen capsules, 350 mg, 60-count bottle, Signature, 1027 Highway 70 W, Suite 227, Garner, NC 27529, UPC 8 52175 00418 1.", "report_date": "20150513", "classification": "Class I", "openfda": {}, "recalling_firm": "Detox Transforms", "recall_number": "D-0979-2015", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "70444", "termination_date": "20170123", "recall_initiation_date": "20150125", "postal_code": "27529-2501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0250-2020", "product_description": "S-SODIUM SELINITE 0.219% INJ, 19ml glass vials, Rx only, Red Mountain Compounding Rx", "product_quantity": "11x10 ml glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #: S03062019JL@11, Exp 9/6/19; S04282019DH@05, Exp 10/28/19; S06182019DT@04, Exp 12/18/19; S06242019DH@11, Exp 12/24/19; \" S07232019DH@15, Exp 1/23/20"}, {"status": "Terminated", "city": "Miami Lakes", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83190", "recalling_firm": "Pharma-Natural Inc.", "address_1": "14500 Nw 60th Ave Bldg 7f", "address_2": "N/A", "postal_code": "33014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Consignees in FL and TX who may have further distributed Nationwide in the USA and Puerto Rico.", "recall_number": "D-1497-2019", "product_description": "GENCONTUSS (Chlorpheniramine Maleate, 2mg; Dextromethorphan HBr, 10 mg; Phenylephrine HCl, 5 mg) in each 5 mL tsp, Cherry Flavor, 16 fl oz (474 mL) bottle, Manufactured in the USA for Kramer Novis, San Juan, PR 00917, NDC 52083-650-16.", "product_quantity": "3000 bottles", "reason_for_recall": "CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.", "recall_initiation_date": "20190621", "center_classification_date": "20190723", "termination_date": "20211027", "report_date": "20190731", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; OMEGA-3 FATTY ACID, Capsule, 1000 mg may be potentially mislabeled as    NORTRIPTYLINE HCL, Capsule, 50 mg, NDC 00093081201, Pedigree: AD21790_70, EXP: 5/1/2014.", "address_2": "", "product_quantity": "90 Capsules", "code_info": "OMEGA-3 FATTY ACID, Capsule, 1000 mg has the following code    Pedigree: AD21858_4, EXP: 5/1/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "OMEGA-3 FATTY ACID, Capsule, 1000 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 05445800022", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-496-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "2 containers", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Hydroxocobalamin 1mg Injection, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0471-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-463-2013", "product_description": "Trimix Inj 30:1:40 MDV, 5 ml  Penile Injection, 30 and 90 day expiration,", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0254-2020", "product_description": "S-TRIMIX (15MG/0.5MG/10MCG/ML) INJ, Rx Only, 5ml glass vial, Red Mountain Compounding Rx.", "product_quantity": "1x5ml glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:  S06142019DH@01, Exp 8/14/19;"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0602-2019", "product_description": "Dr. King's Natural Medicine Homeopathic No Sweat Anti-Perspirant, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955508526, NDC 57955-5085-2", "product_quantity": "181 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 012616E Exp. 01/2019; 060716B Exp. 06/19"}, {"status": "Terminated", "city": "Chicago", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77959", "recalling_firm": "Bella Pharmaceuticals, Inc.", "address_1": "3101 W Devon Ave", "address_2": "N/A", "postal_code": "60659-1407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within USA", "recall_number": "D-1151-2017", "product_description": "B-Complex, 30 mL vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659,1 (877) BELLA.", "product_quantity": "45 vials", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20170815", "center_classification_date": "20170912", "termination_date": "20180423", "report_date": "20170920", "code_info": "Lot #: BPBC3080517, Exp. 2/5/18"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-464-2013", "product_description": "Trimix Inj 30:3:5 MDV, 10ml  Penile Injection, 90 day expiration,", "product_quantity": "1", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Ongoing", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91952", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0527-2023", "product_description": "Glimepiride Tablets USP, 4 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8066-9", "product_quantity": "15 Bottles", "reason_for_recall": "cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.", "recall_initiation_date": "20230323", "center_classification_date": "20230406", "report_date": "20230412", "code_info": "Lot: H1221Z, I0121J, J0622X, Exp 10/31/2023.", "more_code_info": ""}, {"status": "Terminated", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80005", "recalling_firm": "Coast Quality Pharmacy LLC", "address_1": "5710 Hoover Blvd", "address_2": "N/A", "postal_code": "33634-5339", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AL, CA, FL, MI, SC, TX", "recall_number": "D-0801-2018", "product_description": "Macroaggregated albumin (MAA) kit (for the preparation of Tc99m MAA), Aggregated and non-Aggregated Human Serum Albumin 2.5-5 mg Sodium Acetate Sol 200 mL/0.125 mL lyophilized powder in 10 mL glass vial, Rx only, AnazaoHealth, Tampa, FL", "product_quantity": "52 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180426", "center_classification_date": "20180510", "termination_date": "20200604", "report_date": "20180516", "code_info": "Lot: MAA-171219BM BUD: 4/19/18; MAA-180226BM BUD: 06/26/18"}, {"status": "Terminated", "city": "Jeannette", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80633", "recalling_firm": "Ranier's Compounding Laboratory", "address_1": "1107 Lowry Ave", "address_2": "", "postal_code": "15644-3030", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed within the state of Pennsylvania.", "recall_number": "D-1083-2018", "product_description": "Triple P (Prostaglandin/Papaverine/Phentolamine) Injection, 0.008/22.5/0.83 mg/mL, packaged in a) 5 mL and b) 10 mL vials, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.", "product_quantity": "a) 1 vial; b) 1 vial", "reason_for_recall": "Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.", "recall_initiation_date": "20180725", "center_classification_date": "20180815", "termination_date": "20220901", "report_date": "20180822", "code_info": "All lots within expiry", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-499-2015", "product_description": "Acetazolamide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "2100 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77771", "recalling_firm": "Vi-Jon, Inc.", "address_1": "1 Swan Dr", "address_2": "N/A", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "GA, PA, NJ", "recall_number": "D-1054-2017", "product_description": "Magnesium Citrate Oral Solution, packaged in a 10 fl. oz. (296 mL) glass bottle, OTC, labeled as: a) GoodSense Magnesium Citrate Oral Solution Saline Laxative Very Low Sodium, UPC# 846036007381, NDC 50804-686-38, Distributed by: Geiss, Desitin &Dunn, Inc., Peachtree City, GA 30269; b) Premier Value Magnesium Citrate Oral Solution saline laxative very low sodium, UPC# 840986010255, NDC 68016-826-38, Distributed by: Chain Drug Consortium, Boca Raton, FL 33431; c) Swan Very Low Sodium Citroma Magnesium Citrate, UPC# 308690686383, NDC 0869-686-38, Distributed by: Vi-Jon, Smyrna, TN, 37167 ; d) ShopRite Magnesium Citrate Oral Solution Saline Laxative Low Sodium, UPC# 041190211487, NDC 41190-686-38, Distributed by: Wakefern Food Corporation, Jamesburg, NJ 08831", "product_quantity": "101,244 bottles", "reason_for_recall": "Microbial contamination of non-sterile products: product was found to contain mold, identified as Rhinocladiella similis.", "recall_initiation_date": "20170717", "center_classification_date": "20170803", "termination_date": "20200124", "report_date": "20170809", "code_info": "Lot#: a) 0341906, Exp 12/2018; b) 0341906 Exp 12/2018; c) 0341906, Exp 12/2018; 0343709, Exp 1/2019 d) 0343709 Exp 1/2019"}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "45 containers", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Sermorelin Injection 10mg/10mL,10mg/mL, 20mg/10mL, 9mg/9mL, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0450-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "89364", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0384-2022", "product_description": "QC QUALITY CHOICE, Fexofenadine HCl 60mg and Pseudoephedrine HCl 120mg, Extended-Release Tablets, USP,  Allergy & Congestion, 10 Tablets per box, NDC 63868-729-10, Distributed by C.D.M.A., Inc., 43157 W 9 Mile Rd, Novi, MI 48375, Made in India.", "product_quantity": "9,984 boxes", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20220104", "center_classification_date": "20220118", "termination_date": "20231020", "report_date": "20220126", "code_info": "Lot #s: 79C002624D; 79C002625C, Exp. 4/30/2022."}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0787-2023", "product_description": "Azelastine Hydrochloride Nasal Spray, 0.15%, 105.5 mcg per spray, Rx Only, For Intranasal Use Only, Manufactured by: Hi-Tech Pharmacal Co., INC., Amityville, NY 11701.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0600-2023", "product_description": "Ampicillin and Sulbactam for Injection, USP 3 grams vials, Rx only, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017 USA, NDC 66794-242-41", "product_quantity": "91,860 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: AMANTADINE HCL, Capsule, 100 mg may have potentially been mislabeled as one of the following drugs:  ACARBOSE, Tablet, 25 mg, NDC 00054014025, Pedigree: W002725, EXP: 6/6/2014;  clomiPRAMINE HCl, Capsule, 50 mg, NDC 51672401205, Pedigree: W002998, EXP: 6/11/2014;  ASPIRIN EC DR, Tablet, 81 mg, NDC 49348098015, Pedigree: W003672, EXP: 2/28/2014;  NIACIN TR, Capsule, 500 mg, N", "address_2": "", "product_quantity": "499 Capsules", "code_info": "AMANTADINE HCL, Capsule, 100 mg has the following codes:   Pedigree: W002726, EXP: 6/6/2014;  Pedigree: W002997, EXP: 6/11/2014;  Pedigree: W003674, EXP: 6/25/2014;  Pedigree: W003323, EXP: 6/18/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "AMANTADINE HCL, Capsule, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781204801.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-1003-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup:MINOXIDIL, Tablet, 2.5 mg may have potentially been mislabeled as the following drug:  methylPREDNISolone, Tablet, 4 mg, NDC 00781502201, Pedigree: AD52778_43, EXP: 5/20/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "MINOXIDIL, Tablet, 2.5 mg has the following codes:   Pedigree:  AD52778_49, EXP: 5/20/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MINOXIDIL, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591564201.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-977-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "5 containers", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Marcaine 0.24%/Ethanol 4% Injection, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0437-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}]